BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24500767)

  • 21. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
    Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
    Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. d- Versus l-Glucose Conjugation: Mitochondrial Targeting of a Light-Activated Dual-Mode-of-Action Ruthenium-Based Anticancer Prodrug.
    Lameijer LN; Hopkins SL; Brevé TG; Askes SH; Bonnet S
    Chemistry; 2016 Dec; 22(51):18484-18491. PubMed ID: 27859843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium(II) complexes incorporating 2-(2'-pyridyl)pyrimidine-4-carboxylic acid.
    Nickita N; Gasser G; Pearson P; Belousoff MJ; Goh LY; Bond AM; Deacon GB; Spiccia L
    Inorg Chem; 2009 Jan; 48(1):68-81. PubMed ID: 19053847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
    Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
    Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, DNA binding, photo-induced DNA cleavage, cytotoxicity and apoptosis studies of copper(II) complexes.
    Chen GJ; Qiao X; Qiao PQ; Xu GJ; Xu JY; Tian JL; Gu W; Liu X; Yan SP
    J Inorg Biochem; 2011 Feb; 105(2):119-26. PubMed ID: 21194609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, DNA binding, photo-induced DNA cleavage and cell cytotoxicity studies of a family of light rare earth complexes.
    Chen GJ; Qiao X; Gao CY; Xu GJ; Wang ZL; Tian JL; Xu JY; Gu W; Liu X; Yan SP
    J Inorg Biochem; 2012 Apr; 109():90-6. PubMed ID: 22440521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
    Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
    Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light-activated ruthenium (II)-bicalutamide prodrugs for prostate cancer.
    Zhao J; Liu N; Sun S; Gou S; Wang X; Wang Z; Li X; Zhang W
    J Inorg Biochem; 2019 Jul; 196():110684. PubMed ID: 31054419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
    Pal M; Nandi U; Mukherjee D
    Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruthenium(II)-Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells.
    Stephens LJ; Levina A; Trinh I; Blair VL; Werrett MV; Lay PA; Andrews PC
    Chembiochem; 2020 Apr; 21(8):1188-1200. PubMed ID: 31701616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells.
    Lovison D; Allegri L; Baldan F; Ballico M; Damante G; Jandl C; Baratta W
    Dalton Trans; 2020 Jun; 49(24):8375-8388. PubMed ID: 32520028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
    ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
    Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
    Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.